Inovio Pharmaceuticals Inc. Stock Advances 16.9%, Outperforms Peers
Dow Jones2026/08/13 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. surged 16.9% to $0.90 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.8% to 26,803.03 and the Dow Jones Industrial Average rising 0.1% to 53,839.99.
This was the stock's fourth consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 69.8% short of its 52-week high of $2.98, which the company reached on September 9th.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $262.08, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.86% to $26.80.
Trading volume totaled 12.6 million, compared to the 50-day average of 2.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 13, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Overseas capital is aggressively buying US stocks! Net inflows reached $942 billions over the past 12 months, marking a record since 1985.
According to data from the US Department of the Treasury, in the 12 months ending July this year, overseas investors made net purchases of US stocks totaling $942 billion, marking the highest rolling 12-month total since records began in 1985. The net purchases in the second quarter alone reached $426 billion, setting a new single-quarter record. Meanwhile, overseas demand for US Treasuries has noticeably cooled, with purchase volumes falling significantly. As a result, the US is facing higher costs in government debt financing.
RootData: BIO will unlock tokens worth about $1 million in one week
Grayscale Files Zcash ETF That Pays Every 2 Weeks: What's the Catch?
Crypto prices
More
